Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of haloperidol on symptoms of opium withdrawal
IRCT201702131457N12Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of haloperidol in opioid use disorder (OUD), sponsored by Mazandaran University of Medical Sciences. Started Apr 2017; status: completed.
02
Drugs
haloperidol
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on IRCT201702131457N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201702131457N12.